Abstract
Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 206-211 |
| Number of pages | 6 |
| Journal | Current Drug Targets |
| Volume | 12 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Jul 2012 |
Fingerprint
Keywords
- Age-related macular degeneration
- AntiVEGF
- Choroidal neovascularization
- Combination therapy
- Photodynamic therapy
- Polypoidal choroidal vasculopathy
- Triamcinolone
ASJC Scopus subject areas
- Drug Discovery
- Pharmacology
- Clinical Biochemistry
- Molecular Medicine
Cite this
Polypoidal Choroidal Vasculopathy : Recent advances in therapy. / de Crecchio, G.; Chan, R. V P; Manzi, G.; Romano, M. R.
In: Current Drug Targets, Vol. 12, No. 2, 07.2012, p. 206-211.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Polypoidal Choroidal Vasculopathy
T2 - Recent advances in therapy
AU - de Crecchio, G.
AU - Chan, R. V P
AU - Manzi, G.
AU - Romano, M. R.
PY - 2012/7
Y1 - 2012/7
N2 - Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.
AB - Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.
KW - Age-related macular degeneration
KW - AntiVEGF
KW - Choroidal neovascularization
KW - Combination therapy
KW - Photodynamic therapy
KW - Polypoidal choroidal vasculopathy
KW - Triamcinolone
UR - http://www.scopus.com/inward/record.url?scp=79955654604&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955654604&partnerID=8YFLogxK
U2 - 10.2174/138945011794182782
DO - 10.2174/138945011794182782
M3 - Article
C2 - 20887241
AN - SCOPUS:79955654604
VL - 12
SP - 206
EP - 211
JO - Current Drug Targets
JF - Current Drug Targets
SN - 1389-4501
IS - 2
ER -